Results 21 to 30 of about 2,340,675 (258)
Knowing Oldest Old’s Preferences May Improve their Healthcare
Revista Iberoamericana de Bioética, 2020 Oldest old people’s preferences are not taken into account though their importance in healthcare planning. To identify them, we undertook a qualitative study, using in-depth interviews, in a rural area of Toledo, Spain.
Juan Antonio Herrera Tejedor
doaj +1 more source
Where Do I Go to Wait? Ethical Considerations During the 90 Day Reflection Period for MAiD
Canadian Journal of Bioethics, 2023 Canada’s Medical Assistance in Dying (MAID) legislation changed in 2021; persons without a reasonably foreseeable natural death (RFND) could now be eligible for MAID and would have to wait at least 90 days before their intervention.
Kesi Disha +3 more
doaj +1 more source
, 2015 Clinical ethics support services (CESS) are services that aim at supporting health-care professionals (including ancillary staff, managers, and directors), patients, and their families when being confronted with an ethical concern, question, or dilemma.
Molewijk, A.C. +2 more
openaire +6 more sources
Japanese Journal of Radiological Technology, 2010 Physicians engaged in clinical research must address the challenge to determine whether a potential new intervention represents an advance over current methods, whether the new intervention would avoid harms currently incurred, whether it would save lives currently lost.
Ernst Singer, Christiane Druml
openaire +3 more sources
Medical assistance in dying for people living with mental disorders: a qualitative thematic review
BMC Medical Ethics, 2023 Background Medical assistance in dying (MAiD) sparks debate in several countries, some of which allow or plan to allow MAiD where a mental disorder is the sole underlying medical condition (MAiD-MD).
Caroline Favron-Godbout, Eric Racine
doaj +1 more source
Ethics in Clinical Development [PDF]
Journal of the Royal Society of Medicine, 1990 The meeting was convened to provide a forum for the discussion of those aspects of medical ethics which concerned clinical research, particularly the clinical studies which the pharmaceutical industry is required to carry out to satisfy regulatory authorities for them to issue licences for the introduction of new medicines.
openaire +2 more sources
BMC Palliative Care, 2020 Background It is not clear how lay people prioritize the various, sometimes conflicting, interests when they make surrogate medical decisions, especially in non-Western cultures.
Muhammad M. Hammami +3 more
doaj +1 more source
BMC Research Notes, 2020 Objective To evaluate in vitro quality of enteric-coated 50 mg diclofenac sodium tablet formulations on Saudi market. Results A reference and seven generic (G1-7) formulations were commercially available in December 2019/January 2020 and were assessed ...
Muhammad M. Hammami +3 more
doaj +1 more source
Quality assessment of nine paracetamol 500 mg tablet brands marketed in Saudi Arabia
BMC Research Notes, 2021 Objective To evaluate in-vitro quality of paracetamol 500 mg tablet brands marketed in Saudi Arabia. Results Two reference (R1 and R2) and seven generic (G1-G7) brands were commercially available. Four brands were single-drug, containing paracetamol only
Reem AlSwayeh +2 more
doaj +1 more source
BMC Palliative Care, 2022 Background High-quality end-of-life (EOL) care requires both comfort care and the maintenance of dignity. However, delivering EOL in the emergency department (ED) is often challenging.
Jung Sun Kim +10 more
doaj +1 more source